MedTrace Logo

A Remote, 9-week Insomnia Treatment Trial to Collect Real World Data for a Digital Therapeutic

NCT04325464 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1590

Last updated 2023-02-01

No results posted yet for this study

Summary

The purpose of the study is to collect data in a real-world environment, for a digital therapeutic that delivers CBT-I through a decentralized clinical trial, open to participants with chronic insomnia.

Conditions

  • Chronic Insomnia

Interventions

DEVICE

PEAR-003A

PEAR-003A delivers CBT-I through a decentralized clinical trial open to participants with chronic insomnia

Sponsors & Collaborators

  • Pear Therapeutics, Inc.

    lead INDUSTRY

Principal Investigators

  • Abby Doctolero · Pear Therapeutics, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-18
Primary Completion
2022-10-21
Completion
2024-10-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04325464 on ClinicalTrials.gov